← Leaderboards
Mark L Cannon
Weill Medical College Of Cornell Univ
$604,800
Attributed
$604,800
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $125.3K · FY2006–07$200K$150K$100K$50K$0
'06
'07
Funding mix
By agency
NIH$604,800 · 1
By mechanism
K08$604,800 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Enrique A Mesri$8,640,930
- Warren D. Johnson$21,766,636
- Doris A Herzlinger$9,551,423
- Anthony M.c. Brown$7,440,762
- Shahin Rafi$1,722,778
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisLymphomaApoptosisCytokinePhenotypeCell ProliferationCell LineHuman Herpesvirus 8Flow CytometryCell CyclePostdoctoral InvestigatorCell MigrationNeoplastic CellProtein Structure FunctionHyperplasiaHuman TissueKaposi'S SarcomaBiological Signal TransductionG ProteinCytokine ReceptorsHuman Genetic Material TagClinical ResearchLymph NodesReceptor Coupling
Grant awards (6)
Functional analysis of KSHV GPCR in human lymphocytes$125,280
K08 · FY2007 · AI · contact PI
Functional analysis of KSHV GPCR in human lymphocytes$73,440
K08 · FY2006 · AI · contact PI
Functional analysis of KSHV GPCR in human lymphocytes$51,840
K08 · FY2006 · AI · contact PI
Functional analysis of KSHV GPCR in human lymphocytes$125,280
K08 · FY2004 · AI
Functional analysis of KSHV GPCR in human lymphocytes$114,480
K08 · FY2003 · AI
Functional analysis of KSHV GPCR in human lymphocytes$114,480
K08 · FY2002 · AI